Related references
Note: Only part of the references are listed.Antibacterial and antifungal properties of resveratrol
Martin Vestergaard et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Bicarbonate induces high-level resistance to the human antimicrobial peptide LL-37 in Staphylococcus aureus small colony variants
Ping Zhang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Resveratrol enhances the efficacy of aminoglycosides against Staphylococcus aureus
Katrine Nohr-Meldgaard et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Genetic requirements for Staphylococcus aureus nitric oxide resistance and virulence
Melinda R. Grosser et al.
PLOS PATHOGENS (2018)
Antibiotics in the clinical pipeline at the end of 2015
Mark S. Butler et al.
JOURNAL OF ANTIBIOTICS (2017)
Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides
Jessica Z. Kubicek-Sutherland et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of Staphylococcus aureus towards Polymyxins
Martin Vestergaard et al.
MBIO (2017)
Co-infecting microorganisms dramatically alter pathogen gene essentiality during polymicrobial infection
Carolyn B. Ibberson et al.
NATURE MICROBIOLOGY (2017)
The human cathelicidin LL-37 A pore-forming antibacterial peptide and host-cell modulator
Daniela Xhindoli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
D. I. Andersson et al.
DRUG RESISTANCE UPDATES (2016)
Antimicrobial Peptides : An Emerging Category of Therapeutic Agents
Margit Mahlapuu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
The immunology of host defence peptides: beyond antimicrobial activity
Robert E. W. Hancock et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Antimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of Bacteria
Soraya Omardien et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Resveratrol food supplements: a survey on the role of individual consumer characteristics in predicting the attitudes and adoption intentions of US American and Danish respondents
Jessica Aschemann-Witzel et al.
BMC PUBLIC HEALTH (2015)
Antibiotic efficacy is linked to bacterial cellular respiration
Michael A. Lobritz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Bacterial Hypoxic Responses Revealed as Critical Determinants of the Host-Pathogen Outcome by TnSeq Analysis of Staphylococcus aureus Invasive Infection
Aimee D. Wilde et al.
PLOS PATHOGENS (2015)
Small colony variants (SCVs) of Staphylococcus aureus - A bacterial survival strategy
Barbara C. Kahl
INFECTION GENETICS AND EVOLUTION (2014)
Decreased Susceptibility of Staphylococcus aureus Small-Colony Variants toward Human Antimicrobial Peptides
Regine Glaeser et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Genes Contributing to Staphylococcus aureus Fitness in Abscess- and Infection-Related Ecologies
Michael D. Valentino et al.
MBIO (2014)
Platforms for antibiotic discovery
Kim Lewis
NATURE REVIEWS DRUG DISCOVERY (2013)
Neutrophil Function: From Mechanisms to Disease
Borko Amulic et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Novel Antibiotics Targeting Respiratory ATP Synthesis in Gram-Positive Pathogenic Bacteria
Wendy Balemans et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Resveratrol-Containing Gel for the Treatment of Acne Vulgaris A Single-Blind, Vehicle-Controlled, Pilot Study
Gabriella Fabbrocini et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2011)
Persistent Nasal Carriage of Staphylococcus aureus Is Associated with Deficient Induction of Human β-Defensin 3 after Sterile Wounding of Healthy Skin In Vivo
Philipp Zanger et al.
INFECTION AND IMMUNITY (2011)
The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli
Christopher J. Alteri et al.
MOLECULAR MICROBIOLOGY (2011)
Antibiotic Sensitivity Profiles Determined with an Escherichia coli Gene Knockout Collection: Generating an Antibiotic Bar Code
Anne Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Human beta-Defensin 3 Inhibits Cell Wall Biosynthesis in Staphylococci
Vera Sass et al.
INFECTION AND IMMUNITY (2010)
Mechanisms and physiological effects of protamine resistance in Salmonella enterica serovar Typhimurium LT2
Maria Pranting et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Selectivity of TMC207 towards Mycobacterial ATP Synthase Compared with That towards the Eukaryotic Homologue
Anna C. Haagsma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Inhibition of ATPase activity of Escherichia coli ATP synthase by polyphenols
Prasanna K. Dadi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2009)
Pathogenesis of methicillin-resistant Staphylococcus aureus infection
Rachel J. Gordon et al.
CLINICAL INFECTIOUS DISEASES (2008)
Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A2 and human p-defensin 3
Tomaz Koprivnjak et al.
INFECTION AND IMMUNITY (2008)
ATP Synthase and the Actions of Inhibitors Utilized To Study Its Roles in Human Health, Disease, and Other Scientific Areas
Sangjin Hong et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2008)
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Alexandre Prehn Zavascki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on β-defensin 3
Kevin O. Kisich et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols
Jonathan R. Gledhill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections
RA Proctor et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B
O Samuelsen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Synergistic effect of antibacterial agents human β-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli
XJ Chen et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2005)
Human antimicrobial peptides: defensins, cathelicidins and histatins
K De Smet et al.
BIOTECHNOLOGY LETTERS (2005)
Staphylococcus aureus susceptibility to innate antimicrobial peptides, β-defensins and CAP18, expressed by human keratinocytes
K Midorikawa et al.
INFECTION AND IMMUNITY (2003)
Mechanisms of antimicrobial peptide action and resistance
MR Yeaman et al.
PHARMACOLOGICAL REVIEWS (2003)
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine
A Peschel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5
C Gyurko et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
